mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.018 |
0.8 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |